These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24800945)

  • 1. Uptake of compounds that selectively kill multidrug-resistant cells: the copper transporter SLC31A1 (CTR1) increases cellular accumulation of the thiosemicarbazone NSC73306.
    Fung KL; Tepede AK; Pluchino KM; Pouliot LM; Pixley JN; Hall MD; Gottesman MM
    Mol Pharm; 2014 Aug; 11(8):2692-702. PubMed ID: 24800945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.
    Ludwig JA; Szakács G; Martin SE; Chu BF; Cardarelli C; Sauna ZE; Caplen NJ; Fales HM; Ambudkar SV; Weinstein JN; Gottesman MM
    Cancer Res; 2006 May; 66(9):4808-15. PubMed ID: 16651436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.
    Hall MD; Brimacombe KR; Varonka MS; Pluchino KM; Monda JK; Li J; Walsh MJ; Boxer MB; Warren TH; Fales HM; Gottesman MM
    J Med Chem; 2011 Aug; 54(16):5878-89. PubMed ID: 21721528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter.
    Wu CP; Shukla S; Calcagno AM; Hall MD; Gottesman MM; Ambudkar SV
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3287-96. PubMed ID: 18089722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells.
    Beretta GL; Gatti L; Tinelli S; Corna E; Colangelo D; Zunino F; Perego P
    Biochem Pharmacol; 2004 Jul; 68(2):283-91. PubMed ID: 15194000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
    Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatment.
    Landon CD; Benjamin SE; Ashcraft KA; Dewhirst MW
    Int J Hyperthermia; 2013 Sep; 29(6):528-38. PubMed ID: 23879689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
    Howell SB; Safaei R; Larson CA; Sailor MJ
    Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity.
    Pabla N; Murphy RF; Liu K; Dong Z
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F505-11. PubMed ID: 19144690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.
    Kalayda GV; Wagner CH; Jaehde U
    J Inorg Biochem; 2012 Nov; 116():1-10. PubMed ID: 23010323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
    Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.
    Feng C; Ma F; Hu C; Ma JA; Wang J; Zhang Y; Wu F; Hou T; Jiang S; Wang Y; Feng Y
    Cell Cycle; 2018; 17(4):448-458. PubMed ID: 29099271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
    Buß I; Hamacher A; Sarin N; Kassack MU; Kalayda GV
    Metallomics; 2018 Mar; 10(3):414-425. PubMed ID: 29417972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin.
    Matsumoto S; Tanaka T; Kurokawa H; Matsuno K; Hayashida Y; Takahashi T
    Anticancer Res; 2007; 27(4B):2209-16. PubMed ID: 17695505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.
    Lin X; Okuda T; Holzer A; Howell SB
    Mol Pharmacol; 2002 Nov; 62(5):1154-9. PubMed ID: 12391279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
    Wang R; Sun X; Deng YS; Qiu XW
    Xenobiotica; 2019 Nov; 49(11):1373-1378. PubMed ID: 30587068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.
    Blair BG; Larson CA; Safaei R; Howell SB
    Clin Cancer Res; 2009 Jul; 15(13):4312-21. PubMed ID: 19509135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 monobromide, novel small-molecule survivin suppressant, with P-glycoprotein.
    Iwai M; Minematsu T; Li Q; Iwatsubo T; Usui T
    Drug Metab Dispos; 2011 Dec; 39(12):2314-20. PubMed ID: 21918035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.